Robert S. Tissue's most recent trade in Burke & Herbert Financial Services Corp. was a trade of 464 Common Stock done at an average price of $57.4 . Disclosure was reported to the exchange on May 3, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Burke Herbert Financial | Robert S. Tissue | EVP, Financial Strategy | Payment of exercise price or tax liability using portion of securities received from the company at price $ 57.39 per share. | 03 May 2025 | 464 | 47,660 | - | 57.4 | 26,629 | Common Stock |
| Burke Herbert Financial | Robert S. Tissue | EVP, Financial Strategy | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jan 2025 | 4,620 | 38,275 | - | 0 | Common Stock | |
| Burke Herbert Financial | Robert S. Tissue | EVP, Financial Strategy | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Jul 2024 | 5,430 | 0 | - | - | Stock Settled Appreciation Rights | |
| Burke Herbert Financial | Robert S. Tissue | EVP, Financial Strategy | Exercise or conversion of derivative security received from the company (such as an option) at price $ 23.82 per share. | 24 Jul 2024 | 5,430 | 35,684 | - | 23.8 | 129,343 | Common Stock |
| Burke Herbert Financial | Robert S. Tissue | EVP, Financial Strategy | Sale or transfer of securities back to the company at price $ 63.75 per share. | 24 Jul 2024 | 2,029 | 33,655 | - | 63.8 | 129,349 | Common Stock |
| Burke Herbert Financial | Robert S. Tissue | EVP, Financial Strategy | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 May 2024 | 30,254 | 30,254 | - | - | Common Stock | |
| Burke Herbert Financial | Robert S. Tissue | EVP, Financial Strategy | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 May 2024 | 9,865 | 9,865 | - | - | Common Stock | |
| Burke Herbert Financial | Robert S. Tissue | EVP, Financial Strategy | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 May 2024 | 8,684 | 8,684 | - | - | Stock Settled Appreciation Rights | |
| Burke Herbert Financial | Robert S. Tissue | EVP, Financial Strategy | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 May 2024 | 8,599 | 8,599 | - | - | Stock Settled Appreciation Rights | |
| Burke Herbert Financial | Robert S. Tissue | EVP, Financial Strategy | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 May 2024 | 8,436 | 8,436 | - | - | Stock Settled Appreciation Rights | |
| Burke Herbert Financial | Robert S. Tissue | EVP, Financial Strategy | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 May 2024 | 5,430 | 5,430 | - | - | Stock Settled Appreciation Rights | |
| Burke Herbert Financial | Robert S. Tissue | EVP, Financial Strategy | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 May 2024 | 4,110 | 4,110 | - | - | Stock Settled Appreciation Rights | |
| Burke Herbert Financial | Robert S. Tissue | EVP, Financial Strategy | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 May 2024 | 373 | 373 | - | - | Common Stock | |
| Summit Financial Group Inc | Robert S. Tissue | Senior VP & CFO | Other type of transaction at price $ 0.00 per share. | 14 Apr 2023 | 1,409 | 18,410 (0%) | 0% | 0 | Common Stock | |
| Summit Financial Group Inc | Robert S. Tissue | EVP & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2023 | 16,730 | 16,730 | - | - | Stock-Settled Stock Appreciation Rights | |
| Summit Financial Group Inc | Robert S. Tissue | EVP & CFO | Purchase of securities on an exchange or from another person at price $ 26.15 per share. | 02 Feb 2023 | 300 | 59,997 (0%) | 0% | 26.2 | 7,845 | Common Stock |
| Summit Financial Group Inc | Robert S. Tissue | EX VP & CFO | Gift of securities by or to the insider at price $ 0.00 per share. | 31 Dec 2022 | 250 | 59,697 (0%) | 0% | 0 | Common Stock | |
| Summit Financial Group Inc | Robert S. Tissue | EVP & CFO | Other type of transaction at price $ 0.00 per share. | 20 May 2022 | 1,727 | 17,000 (0%) | 0% | 0 | Common Stock | |
| Summit Financial Group Inc | Robert S. Tissue | EVP & CFO | Gift of securities by or to the insider at price $ 0.00 per share. | 27 Dec 2021 | 100 | 59,947 (0%) | 0% | 0 | Common Stock | |
| Summit Financial Group Inc | Robert S. Tissue | EVP & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jul 2021 | 17,221 | 17,221 | - | - | Stock-Settled Stock Appreciation Rights | |
| Summit Financial Group Inc | Robert S. Tissue | EVP & CFO | Other type of transaction at price $ 0.00 per share. | 14 Apr 2021 | 507 | 15,272 (0%) | 0% | 0 | Common Stock | |
| Summit Financial Group Inc | Robert S. Tissue | EVP & CFO | Gift of securities by or to the insider at price $ 0.00 per share. | 06 Nov 2020 | 500 | 60,047 (0%) | 0% | 0 | Common Stock |